Contrast Sensitivity and Patient Reported Outcomes After Bilateral Implantation of a Bi-Aspheric Hydrophobic Trifocal Diffractive Intraocular Lens

Abstract

Purpose

To assess contrast sensitivity and patient reported outcomes after uncomplicated cataract surgery with a new bi-aspheric diffractive trifocal intraocular lens (IOL) implantation.

Methods

Twenty-five patients who underwent bilateral implantation with the Asqelio Trifocal TFLIO130C IOL (AST Products Inc., Billerica, MA, USA) were analyzed at 6 months post-surgery. Binocular contrast sensitivity with and without glare was measured under photopic conditions (85 cd/m²) and mesopic conditions (3 cd/m²). Patients were asked to complete the Catquest-9SF patient outcomes questionnaire and a visual symptoms questionnaire.

Results

Photopic contrast sensitivity values were either within or above normal levels without glare; when glare was induced, the mean sensitivity values dropped just below normal range. Mesopic contrast sensitivity values were above or within normal range both with and without glare, except for 12 cpd with glare, where the mean fell just below the normal range. Differences in binocular contrast sensitivity threshold values with and without glare were significant for all spatial frequencies tested under both photopic and mesopic conditions (p<0.05). The Catquest-9SF questionnaire outcomes showed that 88% of patients were either satisfied or very satisfied with their sight after the surgery, and in all cases, the results indicated no difficulty in performing different daily activities. The visual symptoms questionnaire indicated no relevant visual symptoms regarding frequency, intensity, or bothersomeness after implantation of the trifocal IOL.

Conclusion

This novel bi-aspheric diffractive trifocal IOL provides good contrast sensitivity outcomes under bright and dim lighting conditions. Patients were satisfied with the surgery, with no relevant visual symptoms.

Keywords:

• multifocal intraocular lens
• cataract surgery
• contrast sensitivity
• patient reported outcomes
• visual symptoms

Data Sharing Statement

Data are not available for sharing.

Disclosure

Dr Pedro Tañá-Rivero reports grants from AST Products Inc, during the conduct of the study; grants from Alcon Labs, grants from Carl Zeiss Meditec, grants from Hoya, grants from HumanOptics, grants from Johnson & Johnson, grants from Physiol sa, and grants from Staar Surgical, outside the submitted work. The authors report no other conflicts of interest in this work.

Additional information

Funding

This study was supported by a grant from AST Products Inc.